首页> 外文OA文献 >Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial
【2h】

Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial

机译:纵隔镜与超声内镜在肺癌纵隔淋巴结分期中的一项随机试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mediastinal nodal staging is recommended for patients with resectable non-small cell lung cancer (NSCLC). Surgical staging has limitations, which results in the performance of unnecessary thoracotomies. Current guidelines acknowledge minimally invasive endosonography followed by surgical staging (if no nodal metastases are found by endosonography) as an alternative to immediate surgical staging. To compare the 2 recommended lung cancer staging strategies. Randomized controlled multicenter trial (Ghent, Leiden, Leuven, Papworth) conducted between February 2007 and April 2009 in 241 patients with resectable (suspected) NSCLC in whom mediastinal staging was indicated based on computed or positron emission tomography. Either surgical staging or endosonography (combined transesophageal and endobronchial ultrasound [EUS-FNA and EBUS-TBNA]) followed by surgical staging in case no nodal metastases were found at endosonography. Thoracotomy with lymph node dissection was performed when there was no evidence of mediastinal tumor spread. The primary outcome was sensitivity for mediastinal nodal (N2/N3) metastases. The reference standard was surgical pathological staging. Secondary outcomes were rates of unnecessary thoracotomy and complications. Two hundred forty-one patients were randomized, 118 to surgical staging and 123 to endosonography, of whom 65 also underwent surgical staging. Nodal metastases were found in 41 patients (35%; 95% confidence interval [CI], 27%-44%) by surgical staging vs 56 patients (46%; 95% CI, 37%-54%) by endosonography (P = .11) and in 62 patients (50%; 95% CI, 42%-59%) by endosonography followed by surgical staging (P = .02). This corresponded to sensitivities of 79% (41/52; 95% CI, 66%-88%) vs 85% (56/66; 95% CI, 74%-92%) (P = .47) and 94% (62/66; 95% CI, 85%-98%) (P = .02). Thoracotomy was unnecessary in 21 patients (18%; 95% CI, 12%-26%) in the mediastinoscopy group vs 9 (7%; 95% CI, 4%-13%) in the endosonography group (P = .02). The complication rate was similar in both groups. Among patients with (suspected) NSCLC, a staging strategy combining endosonography and surgical staging compared with surgical staging alone resulted in greater sensitivity for mediastinal nodal metastases and fewer unnecessary thoracotomies. clinicaltrials.gov Identifier: NCT00432640
机译:对于可切除的非小细胞肺癌(NSCLC)患者,建议进行纵隔淋巴结分期。手术分期有局限性,导致进行不必要的开胸手术。当前的指南认为,微创超声内镜检查后应进行手术分期(如果超声内镜未发现淋巴结转移),以作为立即手术分期的替代方法。比较两种推荐的肺癌分期策略。在2007年2月至2009年4月之间,对241例可切除(可疑)NSCLC患者进行了随机对照多中心试验(Ghent,Leiden,Leuven,Papworth),根据计算机或正电子发射断层扫描显示了纵隔分期。手术分期或超声内镜检查(经食道和支气管内超声联合检查[EUS-FNA和EBUS-TBNA]),如果在超声内镜下未发现淋巴结转移,则进行手术分期。当没有纵隔肿瘤扩散的证据时,进行开胸行淋巴结清扫术。主要结果是对纵隔淋巴结(N2 / N3)转移的敏感性。参考标准是手术病理分期。次要结果是不必要的开胸手术和并发症发生率。 241例患者被随机分配,其中118例接受手术分期,123例接受内镜检查,其中65例也接受了手术分期。术中发现41例患者(35%; 95%可信区间[CI],27%-44%)发生淋巴结转移,而超声内镜检查发现56例患者(46%; 95%CI,37%-54%)发生淋巴结转移(P = .11),在62例患者中(50%; 95%CI,42%-59%)进行了内镜检查,随后进行了手术分期(P = .02)。这对应于79%(41/52; 95%CI,66%-88%)的敏感性,而85%(56/66; 95%CI,74%-92%)(P = 0.47)和94%( 62/66; 95%CI,85%-98%)(P = .02)。纵隔内窥镜检查组有21例患者(18%; 95%CI,12%-26%)不需要开胸手术,而内窥镜检查组有9例(7%; 95%CI,4%-13%)(P = .02) 。两组的并发症发生率相似。在患有(疑似)NSCLC的患者中,与单独进行手术分期相比,结合超声内镜和手术分期的分期策略可提高对纵隔淋巴结转移的敏感性,并减少不必要的胸廓切开术。 Clinicaltrials.gov标识符:NCT00432640

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号